Interestingly, while the former study reported high KISS1 levels in pre-operative EOC primary tumors, Yu et al. (42) found that KISS1 immunostaining was much lower in 207 primary EOC biopsies compared to control biopsies (60 benign tumors, serous- or mucinous-cystadenoma). This evidence concerns the gene KISS1 and benign neoplasm.